The IOZK is a translational institution in the field of immunological oncology, where promising results of basic research are transferred into medical therapy. In 2015, the centre became the first institute in Europe to receive approval for the for the production of the individual IO-VAC® vaccine for the treatment of tumours...
The purpose of the non-profit IOZK Foundation is to foster the scientific fundaments of immuno-oncologic research in the fight against cancer.